These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 25298408)

  • 81. A new homozygous HERC1 gain-of-function variant in MDFPMR syndrome leads to mTORC1 hyperactivation and reduced autophagy during cell catabolism.
    Schwarz JM; Pedrazza L; Stenzel W; Rosa JL; Schuelke M; Straussberg R
    Mol Genet Metab; 2020; 131(1-2):126-134. PubMed ID: 32921582
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Purkinje cells derived from TSC patients display hypoexcitability and synaptic deficits associated with reduced FMRP levels and reversed by rapamycin.
    Sundberg M; Tochitsky I; Buchholz DE; Winden K; Kujala V; Kapur K; Cataltepe D; Turner D; Han MJ; Woolf CJ; Hatten ME; Sahin M
    Mol Psychiatry; 2018 Nov; 23(11):2167-2183. PubMed ID: 29449635
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Sustained activation of mTORC1 in macrophages increases AMPKα-dependent autophagy to maintain cellular homeostasis.
    Pan H; Zhong XP; Lee S
    BMC Biochem; 2016 Jul; 17(1):14. PubMed ID: 27387347
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex.
    Salussolia CL; Klonowska K; Kwiatkowski DJ; Sahin M
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():217-240. PubMed ID: 31018109
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Ursolic acid inhibits leucine-stimulated mTORC1 signaling by suppressing mTOR localization to lysosome.
    Ou X; Liu M; Luo H; Dong LQ; Liu F
    PLoS One; 2014; 9(4):e95393. PubMed ID: 24740400
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Critical role of SCD1 in autophagy regulation via lipogenesis and lipid rafts-coupled AKT-FOXO1 signaling pathway.
    Tan SH; Shui G; Zhou J; Shi Y; Huang J; Xia D; Wenk MR; Shen HM
    Autophagy; 2014 Feb; 10(2):226-42. PubMed ID: 24296537
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Tuberin Regulates Prostaglandin Receptor-Mediated Viability, via Rheb, in mTORC1-Hyperactive Cells.
    Li C; Liu X; Liu Y; Zhang E; Medepalli K; Masuda K; Li N; Wikenheiser-Brokamp KA; Osterburg A; Borchers MT; Kopras EJ; Plas DR; Sun J; Franz DN; Capal JK; Mays M; Sun Y; Kwiatkowski DJ; Alayev A; Holz MK; Krueger DA; Siroky BJ; Yu JJ
    Mol Cancer Res; 2017 Oct; 15(10):1318-1330. PubMed ID: 28710231
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tubers from patients with tuberous sclerosis complex are characterized by changes in microtubule biology through ROCK2 signalling.
    Ferrer I; Mohan P; Chen H; Castellsague J; Gómez-Baldó L; Carmona M; García N; Aguilar H; Jiang J; Skowron M; Nellist M; Ampuero I; Russi A; Lázaro C; Maxwell CA; Pujana MA
    J Pathol; 2014 Jul; 233(3):247-57. PubMed ID: 24604753
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration.
    Reith RM; Way S; McKenna J; Haines K; Gambello MJ
    Neurobiol Dis; 2011 Jul; 43(1):113-22. PubMed ID: 21419848
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The non-essential TSC complex component TBC1D7 restricts tissue mTORC1 signaling and brain and neuron growth.
    Schrötter S; Yuskaitis CJ; MacArthur MR; Mitchell SJ; Hosios AM; Osipovich M; Torrence ME; Mitchell JR; Hoxhaj G; Sahin M; Manning BD
    Cell Rep; 2022 May; 39(7):110824. PubMed ID: 35584673
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis.
    Feng Y; Mischler WJ; Gurung AC; Kavanagh TR; Androsov G; Sadow PM; Herbert ZT; Priolo C
    Cancer Res; 2020 Jul; 80(13):2751-2763. PubMed ID: 32393662
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Revisiting Brain Tuberous Sclerosis Complex in Rat and Human: Shared Molecular and Cellular Pathology Leads to Distinct Neurophysiological and Behavioral Phenotypes.
    Kútna V; O'Leary VB; Newman E; Hoschl C; Ovsepian SV
    Neurotherapeutics; 2021 Apr; 18(2):845-858. PubMed ID: 33398801
    [TBL] [Abstract][Full Text] [Related]  

  • 93. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
    Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
    Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
    [TBL] [Abstract][Full Text] [Related]  

  • 94. mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization.
    Gan B; Sahin E; Jiang S; Sanchez-Aguilera A; Scott KL; Chin L; Williams DA; Kwiatkowski DJ; DePinho RA
    Proc Natl Acad Sci U S A; 2008 Dec; 105(49):19384-9. PubMed ID: 19052232
    [TBL] [Abstract][Full Text] [Related]  

  • 95. mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition.
    Bhaskar PT; Nogueira V; Patra KC; Jeon SM; Park Y; Robey RB; Hay N
    Mol Cell Biol; 2009 Sep; 29(18):5136-47. PubMed ID: 19620286
    [TBL] [Abstract][Full Text] [Related]  

  • 96. A novel Hap1-Tsc1 interaction regulates neuronal mTORC1 signaling and morphogenesis in the brain.
    Mejia LA; Litterman N; Ikeuchi Y; de la Torre-Ubieta L; Bennett EJ; Zhang C; Harper JW; Bonni A
    J Neurosci; 2013 Nov; 33(46):18015-21. PubMed ID: 24227713
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse.
    Way SW; McKenna J; Mietzsch U; Reith RM; Wu HC; Gambello MJ
    Hum Mol Genet; 2009 Apr; 18(7):1252-65. PubMed ID: 19150975
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Establishment of Tsc2‑deficient rat embryonic stem cells.
    Ito Y; Kawano H; Kanai F; Nakamura E; Tada N; Takai S; Horie S; Arai H; Kobayashi T; Hino O
    Int J Oncol; 2015 May; 46(5):1944-52. PubMed ID: 25738543
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex.
    Karalis V; Caval-Holme F; Bateup HS
    Nat Commun; 2022 Aug; 13(1):4665. PubMed ID: 35945201
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice.
    Menon S; Yecies JL; Zhang HH; Howell JJ; Nicholatos J; Harputlugil E; Bronson RT; Kwiatkowski DJ; Manning BD
    Sci Signal; 2012 Mar; 5(217):ra24. PubMed ID: 22457330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.